Skip to main content
Log in

Methotrexate

Myelosuppression: 17 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Wei X-N, et al. Older age, hypoalbuminaemia and renal failure might be poor prognosis factors for low dose methotrexate-induced myelosuppression in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 76 (Suppl. 2): 279-280 abstr. THU0201, Jun 2017. Available from: URL: http://doi.org/10.1136/annrheumdis-2017-eular.3723 [abstract] - China

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Methotrexate. Reactions Weekly 1697, 245 (2018). https://doi.org/10.1007/s40278-018-44801-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44801-1

Navigation